In our study, the results showed that PIK3CA-macrozamin, SRC-macrpzamin, and NOS3-lamprolobine had favorable binding energies, further indicating that CKI may treat BC by regulating the VEGF signaling pathway. The gene discussed is SRC; the disease is breast cancer.